During the past decade, Care Access Research - Salt Lake City conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 4 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 4 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Care Access Research - Salt Lake City" #1 sponsor was "Eli Lilly and Company" with 8 trials, followed by "Janssen Research & Development, LLC" with 5 trials sponsored, "Landos Biopharma Inc." with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "Sagimet Biosciences Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Care Access Research - Salt Lake City" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Nektar Therapeutics" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Care Access Research - Salt Lake City" are "Ulcerative Colitis" (7 trials), "Crohn's Disease" (5 trials), "Colitis, Ulcerative" (2 trials), "Crohn Disease" (1 trials) and "Nonalcoholic Fatty Liver Disease" (1 trials). Many other conditions were trialed in "Care Access Research - Salt Lake City" in a lesser frequency.

Most popular intervention types in "Care Access Research - Salt Lake City" are "Drug" (16 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Mirikizumab" (6 trials), "Guselkumab" (3 trials), "Guselkumab Dose 1" (3 trials) and "Guselkumab Dose 2" (3 trials). Other intervention names were less common.

The vast majority of trials in "Care Access Research - Salt Lake City" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Care Access Research - Salt Lake City". undefined are not yet recruiting, 7 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Care Access Research - Salt Lake City, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Care Access Research - Salt Lake City, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".